Is TCEHY or MRK a better dividend investment in 2026?

TCEHY currently yields 0.90% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: MRK offers higher current income.

What is the dividend yield difference between TCEHY and MRK?

TCEHY has a forward dividend yield of 0.90% ($0.57/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1.86 percentage points.

Home › Compare › TCEHY vs MRK

TCEHY vs MRK: Dividend Comparison 2026

TCEHY yields 0.90% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TCEHY wins by $3.19M in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

TCEHY

● Live price

0.90%

Share price

$63.56

Annual div

$0.57

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.25M

Annual income

$2,679,625.04

Full TCEHY calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — TCEHY vs MRK

📍 TCEHY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TCEHY	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TCEHY + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TCEHY pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCEHY

Annual income on $10K today (after 15% tax)

$76.58/yr

After 10yr DRIP, annual income (after tax)

$2,277,681.28/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, TCEHY beats the other by $2,269,352.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCEHY + MRK for your $10,000?

TCEHY: 50%MRK: 50%

100% MRK50/50100% TCEHY

Portfolio after 10yr

$1.65M

Annual income

$1,344,711.59/yr

Blended yield

81.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TCEHY

Analyst Ratings

Buy

Consensus: Buy

Price Target

$102.00

+60.5% upside vs current

Range: $102.00 — $102.00

Altman Z

4.5

Piotroski

7/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCEHY buys

MRK buys

No recent congressional trades found for TCEHY or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTCEHYMRK

Forward yield	0.90%	2.76% ✓
Annual dividend / share	$0.57	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	32.7%
Portfolio after 10y	$3.25M	$56.8K ✓
Annual income after 10y	$2,679,625.04 ✓	$9,798.13
Total dividends collected	$3.18M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy
Analyst price target	$102.00	$128.54 ✓

Year-by-year: TCEHY vs MRK ($10,000, DRIP)

Year	TCEHY Portfolio	TCEHY Income/yr	MRK Portfolio	MRK Income/yr	Gap
1	$10,880	$180.18	$11,206	$366.19	$326.00 → MRK
2	$12,008	$366.43	$12,650	$502.35	$642.00 → MRK
3	$13,605	$755.92	$14,407	$694.19	$802.00 → MRK
4	$16,158	$1,600.79	$16,585	$967.82	$427.00 → MRK
5← crossover	$20,843	$3,553.64	$19,342	$1,363.89	+$1.5K → TCEHY
6	$30,870	$8,568.13	$22,913	$1,947.19	+$8.0K → TCEHY
7	$56,750	$23,719.94	$27,662	$2,823.89	+$29.1K → TCEHY
8	$142,231	$81,507.54	$34,159	$4,173.35	+$108.1K → TCEHY
9	$534,014	$381,827.82	$43,337	$6,308.80	+$490.7K → TCEHY
10	$3,251,021	$2,679,625.04	$56,776	$9,798.13	+$3.19M → TCEHY

TCEHY vs MRK: Complete Analysis 2026

TCEHY — Stock

Tencent Holdings Limited, an investment holding company, provides value-added services (VAS) and Online advertising services in Mainland China and internationally. The company operates through VAS, Online Advertising, FinTech and Business Services, and Others segments. It offers online games and social network services; FinTech and cloud services, and online advertising services. The company is also involved in the production, investment, and distribution of films and television programs for third parties, as well as copyrights licensing, merchandise sales, and other activities. n addition, it develops software; develops and operates online games; and provides information technology, information system integration, asset management, online literature, and online music entertainment services. Tencent Holdings Limited company was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.

Full TCEHY Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this TCEHY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCEHY vs SCHD TCEHY vs JEPI TCEHY vs O TCEHY vs KO TCEHY vs MAIN TCEHY vs JNJ TCEHY vs ABBV TCEHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.